The projections come as National Cancer Institute data notes an increase in uterine cancer cases and deaths over the past 30 ...

Breast cancer is one of the most common cancers among women in the United States. Thanks to decades of fundamental research, ...

Piers Ingram, founder and CEO of Singapore-based Hummingbird Bioscience and its U.S. spin-off Callio Therapeutics, is quietly ...

The relationship between hormone therapy (oestrogen with or without progestogen) and breast cancer risk has been widely ...

We read with great interest the published results of the RADIOSA trial by Giulia Marvaso and colleagues.1 This well designed ...

A Caltech-led team has developed a safe, effective, and painless breast imaging technique that incorporates machine learning ...

A new discovery by the Cold Spring Harbor Laboratory could help point toward the first effective therapy for triple-negative breast cancer. Triple-negative breast cancer accounts for 10 to 15% of all ...

Breast cancer is one of the most common cancers among women in the United States. Thanks to decades of fundamental research, ...

Breast cancer, particularly triple-negative breast cancer (TNBC), remains a leading cause of cancer-related mortality due to ...

In 2022, there were 2.3 million women diagnosed with breast cancer and 670,000 deaths worldwide, according to the World ...

CHICAGO — In this video, Megan Kruse, MD, breast medical oncologist at Cleveland Clinic, discusses primary results from ASCENT-04 evaluating sacituzumab govitecan plus pembrolizumab in ...

CHICAGO — In this video, Megan Kruse, MD, breast medical oncologist at Cleveland Clinic, discusses results from an interim analysis of the DESTINY-Breast09 trial, which were presented at ...